Instil Bio, Inc.·4

Sep 12, 5:00 PM ET

Laumas Sandeep 4

4 · Instil Bio, Inc. · Filed Sep 12, 2025

Insider Transaction Report

Form 4
Period: 2025-09-10
Laumas Sandeep
CFO and CBO
Transactions
  • Sale

    Common Stock

    2025-09-10$23.88/sh12,461$297,5690 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-09-1017,00017,000 total
    Exercise: $11.60Exp: 2034-02-09Common Stock (17,000 underlying)
  • Exercise/Conversion

    Common Stock

    2025-09-10$11.60/sh+17,000$197,20017,000 total
  • Exercise/Conversion

    Common Stock

    2025-09-10$12.68/sh+13,000$164,84030,000 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-09-1013,00030,000 total
    Exercise: $12.68Exp: 2033-01-07Common Stock (13,000 underlying)
  • Sale

    Common Stock

    2025-09-10$23.04/sh17,539$404,09912,461 total
Footnotes (4)
  • [F1]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $22.70 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
  • [F2]The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2).
  • [F3]Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on February 10, 2025 with the remainder vesting in substantially equal monthly tranches thereafter.
  • [F4]Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on January 8, 2024 with the remainder vesting in substantially equal monthly tranches thereafter.

Documents

1 file
  • 4
    wk-form4_1757710851.xmlPrimary

    FORM 4